ING genes work as tumor suppressor genes in the carcinogenesis of head and neck squamous cell carcinoma

Journal of Oncology

Volumn , Issue , 2011, Pages

  Takano, Yasuo ^a,b   Li, Xiaohan ^a   Kikuchi, Keiji ^a  

^a KANAGAWA CANCER CENTER   (Japan)

^b CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

CARCINOGENESIS; CELL CYCLE; CELL DEATH; CELL GROWTH; CHROMATIN; CLINICAL ASSESSMENT; CYTOPLASM; DISEASE MARKER; DNA REPAIR; DOWN REGULATION; EPIGENETICS; GENE; GENETIC TRANSCRIPTION; HEAD AND NECK CARCINOMA; ING1 GENE; ING2 GENE; ING3 GENE; ING4 GENE; ING5 GENE; NUCLEAR LOCALIZATION SIGNAL; NUCLEUS ACCUMBENS; PROTEIN DNA INTERACTION; PROTEIN STRUCTURE; REVIEW; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

EID: 78650780771     PISSN: 16878450     EISSN: 16878469     Source Type: Journal    
DOI: 10.1155/2011/963614     Document Type: Review

References (97)

1. Bez A., Genetic and environmental factors in head and neck cancer genesis Journal of Environmental Science and Health C 2008 26 2 174 200
2. Gillison M. L., Koch W. M., Capone R. B., Spafford M., Westra W. H., Wu L., Zahurak M. L., Daniel R. W., Viglione M., Symer D. E., Shah K. V., Sidransky D., Evidence for a causal association between human papillomavirus and a subset of head and neck cancers Journal of the National Cancer Institute 2000 92 9 709 720
3. D'Souza G., Kreimer A. R., Viscidi R., Pawlita M., Fakhry C., Koch W. M., Westra W. H., Gillison M. L., Case-control study of human papillomavirus and oropharyngeal cancer The New England Journal of Medicine 2007 356 19 1944 1956 (Pubitemid 46740304)
4. Haddad R. I., Shin D. M., Recent advances in head and neck cancer The New England Journal of Medicine 2008 359 11 1143 1154
5. Lai S., Batsakis J. G., Ordonez N. G., Luna M. A., Goepfert H., El-Naggar A. K., Genotypic and phenotypic alterations of p53 in head and neck squamous cell carcinoma Oncology Reports 1995 2 6 1115 1120
6. Gasco M., Crook T., The p53 network in head and neck cancer Oral Oncology 2003 39 3 222 231
7. Weber A., Wittekind C., Tannapfel A., Genetic and epigenetic alterations of 9p21 gene products in benign and malignant tumors of the head and neck Pathology Research and Practice 2003 199 6 391 397
8. Papadimitrakopoulou V. A., Izzo J., Mao L., Cyclin D1 and p16 alterations in advanced premalignant lesions of the upper aerodigestive tract: role in response to chemoprevention and cancer development Clinical Cancer Research 2001 7 10 3127 3134
9. Garkavtsev I., Kazarov A., Gudkov A., Riabowol K., Suppression of the novel growth inhibitor p33(ING1) promotes neoplastic transformation Nature Genetics 1996 14 4 415 420
10. Nagashima M., Shiseki M., Miura K., Hagiwara K., Linke S. P., Pedeux R., Wang X. W., Yokota J., Riabowol K., Harris C. C., DNA damage-inducible gene p33ING2 negatively regulates cell proliferation through acetylation of p53 Proceedings of the National Academy of Sciences of the United States of America 2001 98 17 9671 9676
11. Shimada Y., Saito A., Suzuki M., Takahashi E., Horie M., Cloning of a novel gene (ING1L) homologous to ING1, a candidate tumor suppressor Cytogenetics and Cell Genetics 1998 83 3-4 232 235
12. Nagashima M., Shiseki M., Pedeux R. M., Okamura S., Kitahama-Shiseki M., Miura K., Yokota J., Harris C. C., A novel PHD-finger motif protein, p47ING3, modulates p53-mediated transcription, cell cycle control, and apoptosis Oncogene 2003 22 3 343 350
13. Shiseki M., Nagashima M., Pedeux R. M., Kitahama-Shiseki M., Miura K., Okamura S., Onogi H., Higashimoto Y., Appella E., Yokota J., Harris C. C., p29ING4 and p28ING5 bind to p53 and p300, and enhance p53 activity Cancer Research 2003 63 10 2373 2378
14. Ythier D., Larrieu D., Brambilla C., Brambilla E., Pedeux R., The new tumor suppressor genes ING: genomic structure and status in cancer International Journal of Cancer 2008 123 7 1483 1490
15. Shah S., Smith H., Feng X., Rancourt D. E., Riabowol K., ING function in apoptosis in diverse model systems Biochemistry and Cell Biology 2009 87 1 117 125
16. He G. H. Y., Helbing C. C., Wagner M. J., Sensen C. W., Riabowol K., Phylogenetic analysis of the ING family of PHD finger proteins Molecular Biology and Evolution 2005 22 1 104 116 (Pubitemid 39628547)
17. Saito A., Furukawa T., Fukushige S., Koyama S., Hoshi M., Hayashi Y., Hor A. II, p24/ING1-ALT1 and p47/ING1-ALT2, distinct alternative transcripts of p33/ING1 Journal of Human Genetics 2000 45 3 177 181
18. Unoki M., Kumamoto K., Robles A. I., Shen J. C., Zheng Z.-M., Harris C. C., A novel ING2 isoform, ING2b, synergizes with ING2a to prevent cell cycle arrest and apoptosis FEBS Letters 2008 582 28 3868 3874
19. Unoki M., Shen J. C., Zheng Z.-M., Harris C. C., Novel splice variants of ING4 and their possible roles in the regulation of cell growth and motility Journal of Biological Chemistry 2006 281 45 34677 34686
20. Raho G., Miranda C., Tamborini E., Pierotti M. A., Greco A., Detection of novel mRNA splice variants of human ING4 tumor suppressor gene Oncogene 2007 26 36 5247 5257
21. Coles A. H., Jones S. N., The ING gene family in the regulation of cell growth and tumorigenesis Journal of Cellular Physiology 2009 218 1 45 57
22. Pea P. V., Davrazou F., Shi X., Walter K. L., Verkhusha V. V., Gozani O., Zhao R., Kutateladze T. G., Molecular mechanism of histone H3K4me3 recognition by plant homeodomain of ING2 Nature 2006 442 7098 100 103
23. Ha S., Park S., Yun C. H., Choi Y., Characterization of nuclear localization signal in mouse ING1 homolog protein Biochemical and Biophysical Research Communications 2002 293 1 163 166
24. Scott M., Boisvert F.-M., Vieyra D., Johnston R. N., Bazett-Jones D. P., Riabowol K., UV induces nucleolar translocation of ING1 through two distinct nucleolar targeting sequences Nucleic Acids Research 2001 29 10 2052 2058
25. Soliman M. A., Riabowol K., After a decade of study-ING, a PHD for a versatile family of proteins Trends in Biochemical Sciences 2007 32 11 509 519
26. Wang J., Chin M. Y., Li G., The novel tumor suppressor p33ING2 enhances nucleotide excision repair via inducement of histone H4 acetylation and chromatin relaxation Cancer Research 2006 66 4 1906 1911
27. Han X., Feng X., Rattner J. B., Smith H., Bose P., Suzuki K., Soliman M. A., Scott M. S., Burke B. E., Riabowol K., Tethering by lamin A stabilizes and targets the ING1 tumour suppressor Nature Cell Biology 2008 10 11 1333 1340
28. Gong W., Russell M., Suzuki K., Riabowol K., Subcellular targeting of p33ING1b by phosphorylation-dependent 14-3-3 binding regulates p21WAF1 expression Molecular and Cellular Biology 2006 26 8 2947 2954
29. Unoki M., Kumamoto K., Takenoshita S., Harris C. C., Reviewing the current classification of inhibitor of growth family proteins Cancer Science 2009 100 7 1173 1179
30. Jenuwein T., Allis C. D., Translating the histone code Science 2001 293 5532 1074 1080
31. Skowyra D., Zeremski M., Neznanov N., Li M., Choi Y., Uesugi M., Hauser C. A., Gu W., Gudkov A. V., Qin J., Differential association of products of alternative transcripts of the candidate tumor suppressor ING1 with the mSin3/HDAC1 transcriptional corepressor complex Journal of Biological Chemistry 2001 276 12 8734 8739
32. Vieyra D., Loewith R., Scott M., Bonnefin P., Boisvert F. M., Cheema P., Pastyryeva S., Meijer M., Johnston R. N., Bazett-Jones D. P., McMahon S., Cole M. D., Young D., Riabowol K., Human ING1 proteins differentially regulate histone acetylation Journal of Biological Chemistry 2002 277 33 29832 29839
33. Kuzmichev A., Zhang Y., Erdjument-Bromage H., Tempst P., Reinberg D., Role of the Sin3-histone deacetylase complex in growth regulation by the candidate tumor suppressor p33ING1 Molecular and Cellular Biology 2002 22 3 835 848
34. Pedeux R., Sengupta S., Shen J. C., Demidov O. N., Saito S., Onogi H., Kumamoto K., Wincovitch S., Garfield S. H., McMenamin M., Nagashima M., Grossman S. R., Appella E., Harris C. C., ING2 regulates the onset of replicative senescence by induction of p300-dependent p53 acetylation Molecular and Cellular Biology 2005 25 15 6639 6648
35. Wang Y., Wang J., Li G., Leucine zipper-like domain is required for tumor suppressor ING2-mediated nucleotide excision repair and apoptosis FEBS Letters 2006 580 16 3787 3793
36. Doyon Y., Cayrou C., Ullah M., Landry A.-J., Ct V., Selleck W., Lane W. S., Tan S., Yang X.-J., Ct J., ING tumor suppressor proteins are critical regulators of chromatin acetylation required for genome expression and perpetuation Molecular Cell 2006 21 1 51 64
37. Doyon Y., Selleck W., Lane W. S., Tan S., Ct J., Structural and functional conservation of the NuA4 histone acetyltransferase complex from yeast to humans Molecular and Cellular Biology 2004 24 5 1884 1896
38. Shi X., Hong T., Walter K. L., Ewalt M., Michishita E., Hung T., Carney D., Pea P., Lan F., Kaadige M. R., Lacoste N., Cayrou C., Davrazou F., Saha A., Cairns B. R., Ayer D. E., Kutateladze T. G., Shi Y., Ct J., Chua K. F., Gozani O., ING2 PHD domain links histone H3 lysine 4 methylation to active gene repression Nature 2006 442 7098 96 99
39. Pea P. V., Hom R. A., Hung T., Lin H., Kuo A. J., Wong R. P. C., Subach O. M., Champagne K. S., Zhao R., Verkhusha V. V., Li G., Gozani O., Kutateladze T. G., Histone H3K4me3 binding is required for the DNA repair and apoptotic activities of ING1 tumor suppressor Journal of Molecular Biology 2008 380 2 303 312
40. Palacios A., Garcia P., Padr D., Lpez-Hernndez E., Martn I., Blanco F. J., Solution structure and NMR characterization of the binding to methylated histone tails of the plant homeodomain finger of the tumour suppressor ING4 FEBS Letters 2006 580 30 6903 6908
41. Palacios A., Muoz I. G., Pantoja-Uceda D., Marcaida M. J., Torres D., Martn-Garca J. M., Luque I., Montoya G., Blanco F. J., Molecular basis of histone H3K4me3 recognition by ING4 Journal of Biological Chemistry 2008 283 23 15956 15964
42. Hung T., Binda O., Champagne K. S., Kuo A. J., Johnson K., Chang H. Y., Simon M. D., Kutateladze T. G., Gozani O., ING4 mediates crosstalk between histone H3K4 trimethylation and H3 acetylation to attenuate cellular transformation Molecular Cell 2009 33 2 248 256
43. Vicencio J. M., Galluzzi L., Tajeddine N., Ortiz C., Criollo A., Tasdemir E., Morselli E., Ben Younes A., Maiuri M. C., Lavandero S., Kroemer G., Senescence, apoptosis or autophagy? When a damaged cell must decide its patha mini-review Gerontology 2008 54 2 92 99
44. Gordon P. M. K., Soliman M. A., Bose P., Trinh Q., Sensen C. W., Riabowol K., Interspecies data mining to predict novel ING-protein interactions in human BMC Genomics 2008 9
45. Cheung K.-J. JR., Mitchell D., Lin P., Li G., The tumor suppressor candidate p33ING1 mediates repair of UV-damaged DNA Cancer Research 2001 61 13 4974 4977
46. Campos E. I., Martinka M., Mitchell D. L., Dai D. L., Li G., Mutations of the ING1 tumor suppressor gene detected in human melanoma abrogate nucleotide excision repair International Journal of Oncology 2004 25 1 73 80
47. Scott M., Bonnefin P., Vieyra D., Boisvert F.-M., Young D., Bazett-Jones D. P., Riabowol K., UV-induced binding of ING1 to PCNA regulates the induction of apoptosis Journal of Cell Science 2001 114 19 3455 3462
48. Cheung K.-J. J., Bush J. A., Jia W., Li G., Expression of the novel tumour suppressor p33(ING1) is independent of p53 British Journal of Cancer 2000 83 11 1468 1472
49. Campisi J., D'Adda Di Fagagna F., Cellular senescence: when bad things happen to good cells Nature Reviews Molecular Cell Biology 2007 8 9 729 740
50. Garkavtsev I., Riabowol K., Extension of the replicative life span of human diploid fibroblasts by inhibition of the p33(ING1) candidate tumor suppressor Molecular and Cellular Biology 1997 17 4 2014 2019
51. Goeman F., Thormeyer D., Abad M., Serrano M., Schmidt O., Palmero I., Baniahmad A., Growth inhibition by the tumor suppressor p33ING1 in immortalized and primary cells: involvement of two silencing domains and effect of Ras Molecular and Cellular Biology 2005 25 1 422 431
52. Vieyra D., Toyama T., Hara Y., Boland D., Johnston R., Riabowol K., ING1 isoforms differentially affect apoptosis in a cell age-dependent manner Cancer Research 2002 62 15 4445 4452
53. Pedeux R., Sengupta S., Shen J. C., Demidov O. N., Saito S., Onogi H., Kumamoto K., Wincovitch S., Garfield S. H., McMenamin M., Nagashima M., Grossman S. R., Appella E., Harris C. C., ING2 regulates the onset of replicative senescence by induction of p300-dependent p53 acetylation Molecular and Cellular Biology 2005 25 15 6639 6648
54. Ohgi T., Masaki T., Nakai S., Morishita A., Yukimasa S., Nagai M., Miyauchi Y., Funaki T., Kurokohchi K., Watanabe S., Kuriyama S., Expression of p33ING1 in hepatocellular carcinoma: relationships to tumour differentiation and cyclin E kinase activity Scandinavian Journal of Gastroenterology 2002 37 12 1440 1448
55. Takahashi M., Seki N., Ozaki T., Kato M., Kuno T., Nakagawa T., Watanabe K.-I., Miyazaki K., Ohira M., Hayashi S., Hosoda M., Tokita H., Mizuguchi H., Hayakawa T., Todo S., Nakagawara A., Identification of the p33ING1-regulated genes that include cyclin B1 and protooncogene DEK by using cDNA microarray in a mouse mammary epithelial cell line NMuMG Cancer Research 2002 62 8 2203 2209
56. Xie Y. F., Sheng W., Xiang J., Zhang H., Ye Z., Yang J., Adenovirus-mediated ING4 expression suppresses pancreatic carcinoma cell growth via induction of cell-cycle alteration, apoptosis, and inhibition of tumor angiogenesis Cancer Biotherapy and Radiopharmaceuticals 2009 24 2 261 269
57. Helbing G. C., Veillette C., Riabowol K., Johnston R. N., Garkavtsev I., A novel candidate tumor suppressor, ING1, is involved in the regulation of apoptosis Cancer Research 1997 57 7 1255 1258 (Pubitemid 27152547)
58. Garkavtsev I., Grigorian I. A., Ossovskaya V. S., Chernov M. V., Chumakov P. M., Gudkov A. V., The candidate tumour suppressor p33(ING1) cooperates with p53 in cell growth control Nature 1998 391 6664 295 298
59. Shinoura N., Muramatsu Y., Nishimura M., Yoshida Y., Saito A., Yokoyama T., Furukawa T., Hor A. II, Hashimoto M., Asai A., Kirino T., Hamada H., Adenovirus-mediated transfer of p33(ING1) with p53 drastically augments apoptosis in gliomas Cancer Research 1999 59 21 5521 5528
60. Feng X., Bonni S., Riabowol K., HSP70 induction by ING proteins sensitizes cells to tumor necrosis factor alpha receptor-mediated apoptosis Molecular and Cellular Biology 2006 26 24 9244 9255
61. Gozani O., Karuman P., Jones D. R., Ivanov D., Cha J., Lugovskoy A. A., Baird C. L., Zhu H., Field S. J., Lessnick S. L., Villasenor J., Mehrotra B., Chen J., Rao V. R., Brugge J. S., Ferguson C. G., Payrastre B., Myszka D. G., Cantley L. C., Wagner G., Divecha N., Prestwich G. D., Yuan J., The PHD finger of the chromatin-associated protein ING2 functions as a nuclear phosphoinositide receptor Cell 2003 114 1 99 111
62. Chin M. Y., Ng K. C. P., Li G., The novel tumor suppressor p33ING2 enhances UVB-induced apoptosis in human melanoma cells Experimental Cell Research 2005 304 2 531 543
63. Wang Y., Li G., ING3 promotes UV-induced apoptosis via Fas/caspase-8 pathway in melanoma cells Journal of Biological Chemistry 2006 281 17 11887 11893
64. Harris S. L., Levine A. J., The p53 pathway: positive and negative feedback loops Oncogene 2005 24 17 2899 2908
65. Berardi P., Russell M., El-Osta A., Riabowol K., Functional links between transcription, DNA repair and apoptosis Cellular and Molecular Life Sciences 2004 61 17 2173 2180
66. Campos E. I., Chin M. Y., Kuo W. H., Li G., Biological functions of the ING family tumor suppressors Cellular and Molecular Life Sciences 2004 61 19-20 2597 2613
67. Leung K. M., Po L. S., Tsang F. C., Siu W. Y., Lau A., Ho H. T. B., Poon R. Y. C., The candidate tumor suppressor ING1b can stabilize p53 by disrupting the regulation of p53 by MDM2 Cancer Research 2002 62 17 4890 4893
68. Kichina J. V., Zeremski M., Aris L., Gurova K. V., Walker E., Franks R., Nikitin A. Y., Kiyokawa H., Gudkov A. V., Targeted disruption of the mouse ing1 locus results in reduced body size, hypersensitivity to radiation and elevated incidence of lymphomas Oncogene 2006 25 6 857 866
69. Coles A. H., Liang H., Zhu Z., Marfella C. G. A., Kang J., Imbalzano A. N., Jones S. N., Deletion of p37Ing1 in mice reveals a p53-independent role for Ing1 in the suppression of cell proliferation, apoptosis, and tumorigenesis Cancer Research 2007 67 5 2054 2061
70. Oki E., Maehara Y., Tokunaga E., Kakeji Y., Sugimachi K., Reduced expression of p33(ING1) and the relationship with p53 expression in human gastric cancer Cancer Letters 1999 147 1-2 157 162
71. Kameyama K., Huang C.-L., Liu D., Masuya D., Nakashima T., Sumitomo S., Takami Y., Kinoshita M., Yokomise H., Reduced ING1b gene expression plays an important role in carcinogenesis of non-small cell lung cancer patients Clinical Cancer Research 2003 9 13 4926 4934
72. Garkavtsev I., Kozin S. V., Chernova O., Xu L., Winkler F., Brown E., Barnett G. H., Jain R. K., The candidate tumour suppressor protein ING4 regulates brain tumour growth and angiogenesis Nature 2004 428 6980 328 332
73. Nozell S., Laver T., Moseley D., Nowoslawski L., DeVos M., Atkinson G. P., Harrison K., Nabors L. B., Benveniste E. N., The ING4 tumor suppressor attenuates NF- B activity at the promoters of target genes Molecular and Cellular Biology 2008 28 21 6632 6645
74. Nouman G. S., Angus B., Lunec J., Crosier S., Lodge A., Anderson J. J., Comparative assessment expression of the inhibitor of growth 1 gene (ING1) in normal and neoplastic tissues Hybridoma and Hybridomics 2002 21 1 1 10
75. Nouman G. S., Anderson J. J., Crosier S., Shrimankar J., Lunec J., Angus B., Downregulation of nuclear expression of the p33ING1b inhibitor of growth protein in invasive carcinoma of the breast Journal of Clinical Pathology 2003 56 7 507 511
76. Li M., Jin Y., Sun W.-J., Yu Y., Bai J., Tong D.-D., Qi J.-P., Du J.-R., Geng J.-S., Huang Q., Huang X.-Y., Huang Y., Han F.-F., Meng X.-N., Rosales J. L., Lee K.-Y., Fu S.-B., Reduced expression and novel splice variants of ING4 in human gastric adenocarcinoma Journal of Pathology 2009 219 1 87 95
77. Chen L., Matsubara N., Yoshino T., Nagasaka T., Hoshizima N., Shirakawa Y., Naomoto Y., Isozaki H., Riabowol K., Tanaka N., Genetic alterations of candidate tumor suppressor ING1 in human esophageal squamous cell cancer Cancer Research 2001 61 11 4345 4349
78. Nouman G. S., Anderson J. J., Wood K. M., Lunec J., Hall A. G., Reid M. M., Angus B., Loss of nuclear expression of the p33ING1b inhibitor of growth protein in childhood acute lymphoblastic leukaemia Journal of Clinical Pathology 2002 55 8 596 601
79. Vieyra D., Senger D. L., Toyam T., Muzik H., Brasher P. M. A., Johnston R. N., Riabowol K., Forsyth P. A., Altered subcellular localization and low frequency of mutations of ING1 in human brain tumors Clinical Cancer Research 2003 9 16 5952 5961
80. Li X., Nishida T., Noguchi A., Zheng Y., Takahashi H., Yang X., Masuda S., Takano Y., Decreased nuclear expression and increased cytoplasmic expression of ING5 may be linked to tumorigenesis and progression in human head and neck squamous cell carcinoma Journal of Cancer Research and Clinical Oncology 2010 136 10 1573 1583
81. Lu F., Dai D. L., Martinka M., Ho V., Li G., Nuclear ING2 expression is reduced in human cutaneous melanomas British Journal of Cancer 2006 95 1 80 86
82. Borkosky S. S., Gunduz M., Nagatsuka H., Beder L. B., Gunduz E., Al Sheikh Ali M., Rodriguez A. P., Cilek M. Z., Tominaga S., Yamanaka N., Shimizu K., Nagai N., Frequent deletion of ING2 locus at 4q35.1 associates with advanced tumor stage in head and neck squamous cell carcinoma Journal of Cancer Research and Clinical Oncology 2009 135 5 703 713
83. Kumamoto K., Fujita K., Kurotani R., Saito M., Unoki M., Hagiwara N., Shiga H., Bowman E. D., Yanaihara N., Okamura S., Nagashima M., Miyamoto K., Takenoshita S., Yokota J., Harris C. C., ING2 is upregulated in colon cancer and increases invasion by enhanced MMP13 expression International Journal of Cancer 2009 125 6 1306 1315
84. Sarker K. P., Kataoka H., Chan A., Netherton S. J., Pot I., Huynh M. A., Feng X., Bonni A., Riabowol K., Bonni S., ING2 as a novel mediator of transforming growth factor- -dependent responses in epithelial cells Journal of Biological Chemistry 2008 283 19 13269 13279
85. Zhang J.-T., Wang D.-W., Li Q.-X., Zhu Z.-L., Wang M.-W., Cui D.-S., Yang Y.-H., Gu Y.-X., Sun X.-F., Nuclear to cytoplasmic shift of p33ING1b protein from normal oral mucosa to oral squamous cell carcinoma in relation to clinicopathological variables Journal of Cancer Research and Clinical Oncology 2008 134 3 421 426
86. Li X. H., Noguchi A., Nishida T., Cytoplasmic expression of p33ING1b is correlated with tumorigenesis and progression of head and neck squamous cell carcinoma. Histology and Histopathology, accepted
87. Gunduz M., Nagatsuka H., Demircan K., Gunduz E., Cengiz B., Ouchida M., Tsujigiwa H., Yamachika E., Fukushima K., Beder L., Hirohata S., Ninomiya Y., Nishizaki K., Shimizu K., Nagai N., Frequent deletion and down-regulation of ING4, a candidate tumor suppressor gene at 12p13, in head and neck squamous cell carcinomas Gene 2005 356 1-2 109 117
88. Sanchez-Cespedes M., Okami K., Cairns P., Sidransky D., Molecular analysis of the candidate tumor suppressor gene INGI in human head and neck tumors with 13q deletions Genes Chromosomes and Cancer 2000 27 3 319 322
89. Gunduz M., Ouchida M., Fukushima K., Hanafusa H., Etani T., Nishioka S., Nishizaki K., Shimizu K., Genomic structure of the human ING1 gene and tumor-specific mutations detected in head and neck squamous cell carcinomas Cancer Research 2000 60 12 3143 3146
90. Tachibana M., Shinagawa Y., Kawamata H., Omotehara F., Horiuchi H., Ohkura Y., Kubota K., Imai Y., Fujibayashi T., Fujimori T., RT-PCR amplification of RNA extracted from formalin-fixed, paraffin-embedded oral cancer sections: analysis of p53 pathway Anticancer Research 2003 23 3C 2891 2896
91. Gunduz M., Ouchida M., Fukushima K., Ito S., Jitsumori Y., Nakashima T., Nagai N., Nishizaki K., Shimizu K., Allelic loss and reduced expression of the ING3, a candidate tumor suppressor gene at 7q31, in human head and neck cancers Oncogene 2002 21 28 4462 4470
92. Gunduz M., Beder L. B., Gunduz E., Nagatsuka H., Fukushima K., Pehlivan D., Cetin E., Yamanaka N., Nishizaki K., Shimizu K., Nagai N., Downregulation of ING3 mRNA expression predicts poor prognosis in head and neck cancer Cancer Science 2008 29 3 531 538
93. Li X. H., Nishida T., Noguchi A., Decreased nuclear expression and increased cytoplasmic expression of ING4 is correlated with tumorigenesis and progression of head and neck squamous cell carcinoma (HNSCC). submitted for publication
94. Cengiz B., Gunduz E., Gunduz M., Beder L. B., Tamamura R., Bagci C., Yamanaka N., Shimizu K., Nagatsuka H., Tumor-specific mutation and downregulation of ING5 detected in oral squamous cell carcinoma International Journal of Cancer 2010 127 9 2088 2094
95. Hermeking H., Benzinger A., 14-3-3 proteins in cell cycle regulation Seminars in Cancer Biology 2006 16 3 183 192
96. Russell M. W., Soliman M. A., Schriemer D., Riabowol K., ING1 protein targeting to the nucleus by karyopherins is necessary for activation of p21 Biochemical and Biophysical Research Communications 2008 374 3 490 495
97. Unoki M., Kumamoto K., Harris C. C., ING proteins as potential anticancer drug targets Current Drug Targets 2009 10 5 442 454